TY  - CONF

T1  - 2302P Efficacy assessment of targeted and immunotherapies for personalised treatment of melanoma using 2D and 3D ex-vivo assays

JO  - Annals of Oncology

UR  - http://dx.doi.org/10.1016/j.annonc.2023.09.1329

PY  - 2023/10/01

AU  - Rahman MM

AU  - Wells G

AU  - Rantala J

AU  - Helleday T

AU  - Muthana M

AU  - Danson S

ED  - 

DO  - DOI: 10.1016/j.annonc.2023.09.1329

PB  - Elsevier BV

VL  - 34

SP  - S1177

EP  - S1177

Y2  - 2024/12/21

ER  -